Tofacitinib in Depression (TIDE)

NCT04141904 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Covid-19 pandemic

Conditions

Depression
Inflammation

Interventions

DRUG: Tofacitinib 5 MG [Xeljanz]
OTHER: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]